Yahoo Noticias en Español: “Puedes leer todo lo que quieras, pero si no entiendes las ecuaciones, no entenderás a Einstein”: Sean Carroll, físico y cosmólogo
“Puedes leer todo lo que quieras, pero si no entiendes las ecuaciones, no entenderás a Einstein”: Sean Carroll, físico y cosmólogo
Schrodinger's stock has performed well this year due to AI hype and strength in its drug discovery business. While the company appears attractively valued from a long-term perspective, the tight ...
MSN: Schrodinger Downgraded By Citi After Ending Blood Cancer Drug Trial Tied To 2 Deaths; Retail Voices Concern
Schrodinger shares came under pressure after Citi pulled back its bullish call, cutting the stock to ‘Neutral’ from ‘Buy’ and slashing its price target to $20 from $35. The firm said recent stumbles ...
Schrodinger Downgraded By Citi After Ending Blood Cancer Drug Trial Tied To 2 Deaths; Retail Voices Concern
Schrodinger (SDGR) announced new preclinical data on SGR-3515, its investigational Wee1/Myt1 inhibitor, during a poster session at the 36th EORTC-NCI-AACR Symposium. The data demonstrate that in ...